Doppler echocardiographic and electrocardiographic atrioventricular time intervals in newborn infants: Evaluation of techniques for surveillance of fetuses at risk for congenital heart block

Ultrasound in Obstetrics and Gynecology

Volumn 28, Issue 1, 2006, Pages 57-62

  Bergman, G ^a   Jacobsson, L A ^a   Wahren Herlenius, M ^b   Sonesson, S E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Congenital heart block; Doppler; ECG; Echocardiography; Fetus; Newborn

Indexed keywords

AORTA FLOW; ARTICLE; ASCENDING AORTA; CARDIOVASCULAR RISK; CONGENITAL HEART BLOCK; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ATRIOVENTRICULAR VALVE; HUMAN; HUMAN EXPERIMENT; INFANT; MITRAL VALVE; PRENATAL SCREENING; PRIORITY JOURNAL; SUPERIOR CAVA VEIN; TIME;

ANALYSIS OF VARIANCE; ATRIOVENTRICULAR NODE; BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HEART BLOCK; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; PREGNANCY; REPRODUCIBILITY OF RESULTS;

EID: 33746556781     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.2712     Document Type: Article

References (28)

1. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983; 309: 209-212.
2. Manthorpe T, Manthorpe R. Congenital complete heart block in children of mothers with primary Sjogren's syndrome. Lancet 1992; 340: 1359-1360.
3. Ramsey-Goldman R, Hom D, Deng JS. Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1986; 29: 1269-1273.
4. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, Muscara M, Vignati G, Stramba-Badiale M, Catelli L, Lojacono A, Cavazzana I, Ghirardello A, Vescovi F, Gambari PF, Doria A, Meroni PL, Tincani A. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-1835.
5. Buyon JP, Hiebert R, Copel J. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658-1666.
6. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120: 544-551.
7. McCune AB, Weston WL, Lee LA. Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med 1987; 106: 518-523.
8. Julkunen H, Kaaja R, Siren MK, Mack C, McCready S, Holthofer H, Kurki P, Maddison P. Immune-mediated congenital heart block (CHB): identifying and counseling patients at risk for having children with CHB. Semin Arthritis Rheum 1998; 28: 97-106.
9. Buyon JP, Winchester RJ, Slade SG, Arnett F, Copel J, Friedman D, Lockshin MD. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993; 36: 1263-1273.
10. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002; 46: 1233-1241.
11. Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, Kuchroo VK, Thoren P, Herlenius E, Wahren-Herlenius M. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005; 201: 11-17.
12. Buyon JP, Waltuck J, Kleinman C, Copel J. In utero identification and therapy of congenital heart block. Lupus 1995; 4: 116-121.
13. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999; 42: 2335-2345.
14. Yamada H, Kato EH, Ebina Y, Moriwaki M, Yamamoto R, Furuta I, Fujimoto S. Fetal treatment of congenital heart block ascribed to anti-SSA antibody: case reports with observation of cardiohemodynamics and review of the literature. Am J Reprod Immunol 1999; 42: 226-232.
15. Theander E, Brucato A, Gudmundsson S, Salomonsson S, Wahren-Herlenius M, Manthorpe R. Primary Sjogren's syndrome-treatment of fetal incomplete atrioventricular block with dexamethasone. J Rheumatol 2001; 28: 373-376.
16. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 2004; 50: 1253-1261.
17. Fouron JC. Fetal arrhythmias: the Saint-Justine hospital experience. Prenat Diagn 2004; 24: 1068-1080.
18. Jaeggi ET, Silverman ED, Yoo SJ, Kingdom J. Is immune-mediated complete fetal atrioventricular block reversible by transplacental dexamethasone therapy? Ultrasound Obstet Gynecol 2004; 23: 602-605.
19. Glickstein JS, Buyon J, Friedman D. Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol 2000; 86: 236-239.
20. Andelfinger G, Fouron JC, Sonesson SE, Proulx F. Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques. Am J Cardiol 2001; 88: 1433-1436, A1438.
21. Van Bergen AH, Cuneo BF, Davis N. Prospective echocardiographic evaluation of atrioventricular conduction in fetuses with maternal Sjogren's antibodies. Am J Obstet Gynecol 2004; 191: 1014-1018.
22. Rosenthal D, Druzin M, Chin C, Dubin A. A new therapeutic approach to the fetus with congenital complete heart block: preemptive, targeted therapy with dexamethasone. Obstet Gynecol 1998; 92: 689-691.
23. Dancea A, Fouron JC, Miro J, Skoll A, Lessard M. Correlation between electrocardiographic and ultrasonographic time-interval measurements in fetal lamb heart. Pediatr Res 2000; 47: 324-328.
24. Fouron JC, Proulx F, Miro J, Gosselin J. Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol 2000; 96: 732-736.
25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
26. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346: 1085-1087.
27. Bland M. Clinical measurement: Repeatability and measurement error. In An Introduction to Medical Statistics. Oxford University Press: Oxford, 2000; 269-272.
28. Bland M. Regression and correlation: Intraclass correlation. In An Introduction to Medical Statistics. Oxford University Press: Oxford, 2000; 204-205.